The Role of Triggering Receptor Expressed on Myeloid Cells-2 (Trem2) on Microglia

髓系细胞 2 (Trem2) 表达的触发受体对小胶质细胞的作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): Microglia are known as macrophages of the brain, and as part of the innate immune system they constantly monitor the integrity of the central nervous system (CMS) and respond quickly to insults. Microglia can initiate both inflammatory and anti-inflammatory immune responses, but the mechanisms and signals that activate microglia towards either state are poorly understood. Only a few receptors related to cellular activation or inhibition have been identified on microglia. Triggering receptor expressed on myeloid cells-2 (TREM2) and DAP12 are a receptor complex expressed on the cell surface of microglia, and has been previously characterized as an immunoregulatory molecule on myeloid-derived cells, such as macrophages, immature dendritic cells, and microglia. The TREM2-DAP12 complex is critical to prevent a rare neurodegenerative disease called Nasu-Hakola disease, but ligands and/or cells that stimulate TREM2 are unknown. There is evidence to suggest that TREM2 may be activated by signals from apoptotic neuronal cells that induce phagocytosis by microglia without inducing inflammation. Our specific aims are to demonstrate the function of TREM2 on microglia upon engagement with ligands expressed on neurons in vitro and in vivo. Our work will explore the importance of TREM2 during the neurodegenerative disease, Parkinson's disease, which is one of the most common neurodegenerative disorders where excessive microglial inflammatory responses are considered harmful. The long-term objectives of this project are to elucidate the role of TREM2 on microglia, and to understand the importance of this receptor during neuroinflammation and neurodegeneration, and improve human health. The significance of understanding the role of TREM2 may be applied to multiple neurological and immunological diseases.
描述(申请人提供):小胶质细胞被称为大脑的巨噬细胞,作为先天免疫系统的一部分,它们不断监测中枢神经系统(CMS)的完整性,并对侮辱做出快速反应。小胶质细胞既可以启动炎症免疫反应,也可以启动抗炎免疫反应,但激活小胶质细胞达到这两种状态的机制和信号还知之甚少。目前仅在小胶质细胞上发现了与细胞激活或抑制相关的少数受体。表达于髓系细胞上的触发受体-2(TREM2)和DAP12是一种表达于小胶质细胞表面的受体复合体,已被认为是巨噬细胞、未成熟树突状细胞和小胶质细胞等髓系细胞上的免疫调节分子。TREM2-DAP12复合体对于预防一种名为Nasu-Hakola病的罕见神经退行性疾病至关重要,但刺激TREM2的配体和/或细胞尚不清楚。有证据表明,TREM2可能是由凋亡的神经细胞发出的信号激活的,这些信号诱导小胶质细胞吞噬,而不会引发炎症。我们的具体目的是在体外和体内证明TREM2与表达在神经元上的配体结合后对小胶质细胞的作用。我们的工作将探索TREM2在神经退行性疾病帕金森病中的重要性,帕金森病是最常见的神经退行性疾病之一,过度的小胶质细胞炎症反应被认为是有害的。本项目的长期目标是阐明TREM2在小胶质细胞中的作用,了解该受体在神经炎症和神经退行性变中的重要性,并改善人类健康。了解TREM2的作用意义可能应用于多种神经系统和免疫性疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHRISTINE LINDA HSIEH其他文献

CHRISTINE LINDA HSIEH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHRISTINE LINDA HSIEH', 18)}}的其他基金

ShEEP Request for a Replacement Cell Sorting Flow Cytometer for the Flow Cytometry Core Facility
ShEEP 请求为流式细胞术核心设施更换细胞分选流式细胞仪
  • 批准号:
    9793614
  • 财政年份:
    2019
  • 资助金额:
    $ 4.68万
  • 项目类别:
Analysis of a Type I Interferon Responsive Microglia Subset in Traumatic Brain Injury
创伤性脑损伤中 I 型干扰素反应性小胶质细胞亚群的分析
  • 批准号:
    10514571
  • 财政年份:
    2015
  • 资助金额:
    $ 4.68万
  • 项目类别:
Analysis of a Type I Interferon Responsive Microglia Subset in Traumatic Brain Injury
创伤性脑损伤中 I 型干扰素反应性小胶质细胞亚群的分析
  • 批准号:
    10011255
  • 财政年份:
    2015
  • 资助金额:
    $ 4.68万
  • 项目类别:
Targeting CCR2 (CC Chemokine Receptor 2) to treat TBI
靶向 CCR2(CC 趋化因子受体 2)治疗 TBI
  • 批准号:
    9030848
  • 财政年份:
    2015
  • 资助金额:
    $ 4.68万
  • 项目类别:
Analysis of a Type I Interferon Responsive Microglia Subset in Traumatic Brain Injury
创伤性脑损伤中 I 型干扰素反应性小胶质细胞亚群的分析
  • 批准号:
    10293541
  • 财政年份:
    2015
  • 资助金额:
    $ 4.68万
  • 项目类别:
Targeting CCR2 (CC Chemokine Receptor 2) to treat TBI
靶向 CCR2(CC 趋化因子受体 2)治疗 TBI
  • 批准号:
    9487892
  • 财政年份:
    2015
  • 资助金额:
    $ 4.68万
  • 项目类别:
The Role of Triggering Receptor Expressed on Myeloid Cells-2 (Trem2) on Microglia
髓系细胞 2 (Trem2) 表达的触发受体对小胶质细胞的作用
  • 批准号:
    7492659
  • 财政年份:
    2007
  • 资助金额:
    $ 4.68万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了